Ignite Creation Date:
2025-12-24 @ 6:50 PM
Ignite Modification Date:
2025-12-25 @ 4:22 PM
Study NCT ID:
NCT04458857
Status:
COMPLETED
Last Update Posted:
2025-06-22
First Post:
2020-06-22
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Test if Fremanezumab is Effective in Preventing Episodic Migraine in Patients 6 to 17 Years of Age
Sponsor:
Teva Branded Pharmaceutical Products R&D, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2020-06-22
First Submit QC Date:
None
Study First Post Date:
2020-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-02-24
Results First Submit QC Date:
None
Results First Post Date:
2025-04-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-02
Last Update Post Date:
2025-06-22
Last Update Post Date Type:
ACTUAL